Client Solution ServicesWorking with CXR - a flexible approach CXR Biosciences is very flexible in its working relationships as we like to make working with partner companies as easy as possible. We function as a virtual arm of the partner to provide all their ADMET and risk assessment requirements. We provide fee for service research through which clients can access our proprietary technologies and specialist expertise. Drug Development solutions Hits to optimised leads: early ADME & toxicity characterisation of compounds for lead selection and optimisation. Lab Based Due Diligence: identifying and filling crucial data gaps for in and out licencing of compounds. Novel preclinical models: efficacy, DMPK, and toxicity screens that are more rapid, more informative, and more relevant to man. Customised assay development : novel mechanistic assays and screens can be developed to address the client's specific requirements.
Chemical risk assessment solutions Investigative toxicology: to identify the biological mechanisms underlying toxic properties of chemicals. Product Rescue: determine the relevance to man of results from safety or preclinical studies. Product Support: preparing documentation for product support and accreditation.
Research collaborations to develop novel models for drug development and risk assessment.
|
